Trial reportSultan Qaboos University medical journal2026
Comparison of Efficacy of Autologous Platelet Rich Plasma Versus Silicone Products for Treatment of Scars.
Trial report in Sultan Qaboos University medical journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: This study aimed to compare the efficacy of intralesional autologous platelet rich plasma (PRP) injection in post-traumatic and post-surgical scars to a control group managed with silicone-based products. In addition, this study aimed to determine the success rate via aesthetic result, symptom improvement and outcome in terms of complications using autologous PRP on scars caused by burns or trauma. Methods: This randomised controlled trial study was conducted from August 2022 and February 2024 at the Departments of Burns and Plastic Surgery, Surgical Gastroenterology and Obstetrics and Gynaecology, AIIMS, Bhubaneswar, India. Intralesional autologous PRP injections were administered to post-traumatic or post-surgical scars of 6 weeks to 1.5 years duration. The control group was managed with silicone-based products. Clinical outcome of the scars was assessed using the Patient and Observer Scar Assessment Scale (POSAS) to determine improvement in scar characteristics and aesthetics. The Likert scale was also employed to assess the aesthetic satisfaction. Results: A total of 34 patients were included in this study (17 in each group). The PRP group reflected a statistically significant result in terms of both patient and observer factors as a part of the POSAS score. The mean observer POSAS significantly decreased from 16.76 on day 7 to 12.47 at 5 months ( Conclusion: Scars following trauma or surgery showcased a significantly more efficient and faster extent of aesthetic and symptomatic improvement when treated with autologous PRP compared to silicone products.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.